RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 148 filers reported holding RELAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,806,258 | -19.9% | 214,775 | +19.6% | 0.00% | – |
| Q2 2023 | $2,254,733 | -63.8% | 179,517 | -52.6% | 0.00% | -100.0% |
| Q1 2023 | $6,237,140 | +454.3% | 378,697 | +402.8% | 0.00% | – |
| Q4 2022 | $1,125,206 | -80.1% | 75,315 | -70.2% | 0.00% | -100.0% |
| Q3 2022 | $5,658,000 | +85.4% | 252,953 | +38.9% | 0.00% | – |
| Q2 2022 | $3,051,000 | -22.3% | 182,137 | +38.8% | 0.00% | – |
| Q1 2022 | $3,927,000 | -67.3% | 131,180 | -66.4% | 0.00% | – |
| Q4 2021 | $12,008,000 | +238.1% | 390,988 | +247.0% | 0.00% | – |
| Q3 2021 | $3,552,000 | +177.1% | 112,666 | +221.6% | 0.00% | – |
| Q2 2021 | $1,282,000 | -55.3% | 35,033 | -57.8% | 0.00% | – |
| Q1 2021 | $2,869,000 | +193.4% | 82,999 | +252.6% | 0.00% | – |
| Q4 2020 | $978,000 | – | 23,542 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |